• Explore /
  • Poster
  • / Alternating short-course oxaliplatin-based chemotherapy and nivolumab as first-line treatment of patients with abdominal metastases from microsatellite-stable (MSS) colorectal cancer (CRC): A randomized phase 2 trial.

Alternating short-course oxaliplatin-based chemotherapy and nivolumab as first-line treatment of patients with abdominal metastases from microsatellite-stable (MSS) colorectal cancer (CRC): A randomized phase 2 trial.

Abstract Poster

Authors

null

Anne Hansen Ree

Akershus University Hospital, Lorenskog, Norway

Anne Hansen Ree , Jūratė Šaltytė Benth , Hanne M Hamre , Christian Kersten , Eva Hofsli , Marianne G Guren , Halfdan Sorbye , Christin Johansen , Anne Negård , Ying Esbensen , Tonje Bjørnetrø , Hedvig V Juul , Fatemeh Kaveh , Else Marit Inderberg , Hilde Loge Nilsen , Kjersti Flatmark , Sebastian Meltzer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

03388190

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3552)

DOI

10.1200/JCO.2023.41.16_suppl.3552

Abstract #

3552

Poster Bd #

252

Abstract Disclosures

Similar Posters

First Author: Angela Damato

First Author: Angela Damato

First Author: Jin Won Kim

First Author: Axel Grothey